Αρχική World News Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers World News Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers Από Ogkologos - 19 Φεβρουαρίου, 2025 969 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR New Type of Chemotherapy Bypasses Healthy Cells to Decrease Negative Side... 5 Δεκεμβρίου, 2019 Bride’s Escorted Down Aisle By Dad Of Organ Donor Who Saved... 11 Οκτωβρίου, 2021 Opinion: “We’ve been pushing for change for 20 years. We’re not... 24 Ιανουαρίου, 2022 Innovative cancer spinouts: 3 new projects get green light 13 Αυγούστου, 2021 Φόρτωση περισσοτέρων HOT NEWS Triple negative breast cancer drug given initial ‘no’ for NHS in... Haematologic Toxicity Not Increased with Immunochemotherapy Combinations Over Chemotherapy Treatment for... Metformin May Affect Risk of Breast Cancer in Women with Type... ESMO Highlights the Importance of Prioritising the Fight Against Cancer in...